About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts

Press Releases

2017 2018 2019
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

  November 2012
16 Nov  Biocon announces that it has entered into
 an option agreement with Bristol-Myers
 Squibb for Biocon's IN-105, an oral insulin
 drug candidate
Download Pdf

  October 2012
31 Oct  Biocon Announces Positive Results from its
 Global Phase 3 study with Recombinant
 Human Insulin
Download Pdf
31 Oct  GE Capital to invest in Syngene, Biocon's
 Research Services Subsidiary
Download Pdf
30 Oct  Biocon delivers healthy growth in H1FY13
 Research Services & Branded Formulations
 propel strong growth
Download Pdf

  September 2012
24 Sep  Biocon - the only Asian Company to
 Feature in the Global Top 20 BioPharma
Download Pdf
14 Sep  Manipal Education Malaysia and Biocon Ink
 Industry Academia Partnership for the
 Graduate Program & Talent Management
 for Biotech Sector
Download Pdf

  July 2012
25 Jul  Sustained impetus across verticals drives
 Biocon's Q1 growth
Download Pdf
25 Jul  Biocon announces positive results from its
 Phase 1 Comparative PK-PD Study with
 Biosimilar Insulin Glargine
Download Pdf

  June 2012
04 Jun  Abbott Inaugurates First Nutrition R&D
 Center in India in Collaboration with
Download Pdf

  May 2012
16 May  Designing the future of Cancer research
 Symposium on Integrative Research in
Download Pdf
04 May  Abbott Announces Collaboration with
 Syngene to Open First Nutrition Research
 and Development Center in India
Download Pdf

  April 2012
27 Apr  Biocon announces strong growth
 momentum across business verticals drives
 Biocon's 16% YoY increase in revenues in
Download Pdf
05 Apr  Biocon Research Centre Inaugurated by
 Nobel Laureate Prof Kurt Wuthrich
Download Pdf

  March 2012
13 Mar  Biocon and Pfizer Conclude
 Commercialization Agreement
Download Pdf

  January 2012
24 Jan  Biocon's nine-month revenues driven by
 growth in Branded Formulations, Emerging
 Markets and Research Services
Download Pdf
09 Jan  Biocon Announces Positive Efficacy Data
 with its Novel Monoclonal Antibody
 Itolizumab in a Pivotal Psoriasis Study
Download Pdf



Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved